India, Jan. 20 -- image credit- shutterstock

HRV Global Life Sciences (HRV Pharma) hasannounced acomprehensive, multi-year strategic development partnership with SMS LifeSciences (now Haleos Labs).

This exclusive partnership focuses on the development, scale-up and GMP manufacturing ofmultiple orphan-drug and niche-therapeutic APIsfor regulated & semi-regulated markets. The collaboration brings togetherHRV's world-wide market access, commercial footprint across 50+ countries, and its digital, asset-light Virtual API platform, withSMS's deep chemistry capabilities, WHO-GMP aligned manufacturing systems, and proven track record in specialty API production.

Under the agreement, both companies will jointly execute:

The partnership has alr...